The group of disorders that involves loss of previously established memories, loss of ability to generate new memories or loss of ability to learn new information.  The amnestic disorders may occur due to general medical conditions that results in memory disturbances and exposure to certain chemicals like medications, drug of abuse or environmental toxin. Amnestic disorders are caused by chemical or structural damage to the parts of brain.

Structural damage to the parts of brain can be caused due to head injury or trauma, stroke, tumors or cerebrovascular diseases. Chemical changes in the brain can be a result of long-term heavy drug use, excessive intake of alcohol, exposure to toxins such as mercury, lead, carbon monoxide, and certain insecticides. There are main three types of amnesia namely anterograde amnesia, retrograde amnesia and transient global amnesia. Anterograde amnesia is the form of amnesia which occurs due to brain trauma and is characterized by the inability to remember new information. In anterograde amnesia, victims can recall memories and events prior to trauma, however recent experiences and short-term memory disappear.

In retrograde amnesia, the memories after the trauma can be recalled but events before the trauma can’t be remembered. In the third form of amnesia i.e. the transient global amnesia, victim experiences sudden forgetfulness and confusions. There is no identifiable cause for transient global amnesia, but researchers have found that migraines or transient ischemic attacks may trigger this. Transient global amnesia usually has an excellent prognosis for recovery.

Identify the key factors that will drive your company’s growth, Request a brochure of this report here

Amnestic Disorders Therapeutics Market – Competitive Landscape

The global amnestic disorders therapeutics market comprises of large and mid-size vendors. Key players in amnestic disorders therapeutics market include Allergan plc, Troikaa Pharmaceuticals Ltd., Zydus Cadila, Neon Laboratories Limited, Johnson & Johnson, Janssen Pharmaceuticals, Novartis International AG and Merz Pharma GmbH & Co. KGaA,

Novartis AG

Novartis AG is a global healthcare company that develops and provides solutions to the changing needs of patients, worldwide. The company was established in 1996 through a merger of Ciba-Geigy and Sandoz. Presently, it operates through three primary areas: innovative patented medicines (pharmaceuticals), eye care devices (Alcon), and generics (Sandoz). Its innovative medicines segment has two business units: Novartis Pharmaceuticals and Novartis Oncology. Novartis Pharmaceuticals operates multiple categories including neuroscience.

Allergan plc

Allergan plc. engages in the development, manufacture, and commercialization of branded pharmaceuticals, devices, and biologic products. The company’s products cater to diverse therapy areas including central nervous system, ophthalmology, medical aesthetics, gastroenterology, women health, urology, cardiovascular, and anti-infectives.

Merz Pharma GmbH & Co. KGaA

Merz Pharma engages in the development, research, and sale of innovative medical drugs and products for neurological and clinical dermatological purposes. The company operates in the market through its aesthetics and neurotoxins products, which are driving the company towards innovation and strategic acquisitions.

Rising Prevalence of Amnesia will fuel the Amnestic Disorders Therapeutics Market

The global amnestic disorders therapeutics market is subjected to grow during the forecast period. The overall incidence of the amnestic disorders is increasing across the world. According to an article published by National Center for Biotechnology Information, the incidence rate of transient global amnesia (TGA) is around 5.2-10/100,000 per year in the general population. In individuals aged 50 and above, the incidence rate increases to 23.5 to 32/100,000 per year. Majority of the cases have been reported in patients aged 50 to 80 years old.

The global population is aging rapidly. Increasing geriatric population has been the main driver of the amnestic disorders therapeutics market.  According to the WHO, nearly 2 billion people are expected to be aged 60 and above by 2050, accounting for nearly 16.7% of the global population. The population in developed countries such as those in Western Europe, Japan, and the U.S. is aging at a high rate. Some reasons behind it are better health care infrastructure and adoption of advanced medical techniques.

Expanding operations in future? To get the perfect launch ask for a custom report here

High Diagnosis Rate and Rising Disposable Income to boost the Amnestic Disorders Therapeutics Market

Access to various diagnostic and treatment services has improved in developed as well as developing economies in the past few years. This, in turn, has increased the life expectancy of the overall population. North America is expected to account for the highest share of the amnestic disorders therapeutics market in terms of revenue followed by Europe. These two regions are expected to retain their leadership positions throughout the forecast period.

The superiority of these two regions is majorly due to high diagnosis rate, high disposable income, favorable reimbursement scenario, presence of a large number of hospitals and well developed healthcare infrastructure. China and India are the major markets in Asia Pacific that offer large opportunities for the amnestic disorders therapeutics market.  The amnestic disorders therapeutics market in Asia Pacific is projected to expand at the highest CAGR compared to other regions. Expanding health care infrastructure, rising disposable income, and increasing geriatric population are some of the factors that are expected to play a key role in making Asia Pacific the most attractive market.

Amnestic Disorders Therapeutics Market – Segmentation

On the basis of drug type, amnestic disorders therapeutics market is segmented into:

  • Cholinesterase inhibitors
    • donepezil
    • rivastigmine
    • galantamine
    • others
  • Memantine

Based on distribution channel, the amnestic disorders therapeutics market is categorized into:

  • Hospital pharmacies
  • Retail pharmacies
  • Online pharmacies.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Amnestic Disorders Therapeutics Market

Pre Book